1. Current Trends in the Treatment of Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer
   null Palanisamy Sivanandy et al, 2020, Journal of Pharmacy and Nutrition Sciences CrossRef
2. Luteolin enhances erlotinib’s cell proliferation inhibitory and apoptotic effects in glioblastoma cell lines
   Erika Powe et al, 2022, Frontiers in Pharmacology CrossRef
3. Notch Signaling Activation as a Hallmark for Triple-Negative Breast Cancer Subtype
   M. V. Giuli et al, 2019, Journal of Oncology CrossRef
4. Treatment of Triple Negative Cell Lines with Olaparib to Block DNA Repair
   Marina Gobbe Moschetta-Pinheiro et al, 2022, Anti-Cancer Agents in Medicinal Chemistry CrossRef
5. A Drug Screening Reveals Minocycline Hydrochloride as a Therapeutic Option to Prevent Breast Cancer Cells Extravasation across the Blood–Brain Barrier
   Joana Godinho-Pereira et al, 2022, Biomedicines CrossRef
6. Gedunin modulates cellular growth and apoptosis in glioblastoma cell lines
   Michael Stouffer et al, 2024, Cancer Reports CrossRef